Litigation in obstetrics: A lesson learnt and a lesson to share

Taiwanese Journal of Obstetrics and Gynecology

Volumn 45, Issue 1, 2006, Pages 1-9

  Chou, Min Min ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Litigation; Malpractice; Maternal mortality; Obstetrics; Pregnancy

Indexed keywords

AMNION FLUID EMBOLISM; DOCTOR PATIENT RELATION; FETUS OUTCOME; HEALTH INSURANCE; HELLP SYNDROME; HUMAN; LAW SUIT; LUNG EMBOLISM; MALPRACTICE; MATERNAL MORBIDITY; MATERNAL MORTALITY; MEDICAL ERROR; MEDICAL SPECIALIST; MEDICOLEGAL ASPECT; NEGLIGENCE; OBSTETRIC CARE; OBSTETRIC OPERATION; PLACENTA ACCRETA; REVIEW; SEPTIC SHOCK; SHOULDER DYSTOCIA; UTERUS RUPTURE;

EID: 33645729394     PISSN: 10284559     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1028-4559(09)60183-2     Document Type: Review

References (54)

1. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, Syverson CJ. Pregnancy-related mortality surveillance-United States, 1991-1999. MMWR Surveill Summ 2003; 52:1-8.
2. de Swiet M. Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom. Am J Obstet Gynecol 2000;182:760-6.
3. Panting-Kemp A, Geller SE, Nguyen T, Simpson L, Nuwayhid B, Castro L. Maternal deaths in an urban perinatal network, 1992-1998. Am J Obstet Gynecol 2000;183:1207-12.
4. Berg CJ, Harper MA, Atkinson SM, et al. Preventability of pregnancy-related deaths: results of a state-wide reviews. Obstet Gynecol 2005;106:1228-34.
5. Doyle NM, Ramirez MM, Mastrobattista JM, Monga M, Wagner LK, Gardner MO. Diagnosis of pulmonary embolism. A cost-effectiveness analysis. Am J Obstet Gynecol 2004;191: 1019-23.
6. Bechtel JJ, Mountford MC, Ellinwood WE. Massive pulmonary embolisim in pregnancy treated with tissue plasminogen activator. Obstet Gynecol 2005;106:1156-8.
7. Marty AT, Hilton FL, Spear RK, Greyson B. Postcesarean pulmonary embolism, sustained cardiopulmonary resuscitation, embolectomy, and near-death experience. Obstet Gynecol 2005;106:1153-5.
8. Bechtel JJ, Mountford MC, Ellinwood WE. Massive pulmonary embolism in pregnancy treated with catheter fragmentation and local thrombolysis. Obstet Gynecol 2005;106:1158-60.
9. Bonnar J. Can more be done in obstetric and gynecologic practice to reduce morbidity and mortality associated with venous thromboembolism. Am J Obstet Gynecol 1999;180: 784-91.
10. Lockwood CJ. Maternal mortality: we must do better. Contemp Ob Gyn 2002;1:10-4.
11. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001;344:1222-31.
12. Gerhardt A, Scharf RE, Beckmann MW, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N Engl J Med 2000; 342:374-80.
13. Lockwood CJ. Preventing VTE: part 3-the pregnant patient. Contemp Ob Gyn 2005;May 1.
14. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 2002;99: 333-41.
15. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 2005;193:859-63.
16. Sibai BM, Ramadan MK, Usta I, Salama M, Mercer BM, Friedman SA. Maternal morbidity and mortality in 442 pregnancies with hemlolysis, elevated liver enzymes and low platelets. Am J Obstet Gynecol 1993;169:1000-6.
17. Martin JN Jr, May WL, Magann EF Terrone DA, Rinehart BK, Blake PG. Early risk assessment of severe preeclampsia: admission battery of symptoms and laboratory tests to predict likelihood of subsequent significant maternal morbidity. Am J Obstet Gynecol 1999;180:1407-14.
18. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 2004;CD002076.
19. Fonseca JE, Mendez F, Catano C, Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 2005;193: 1591-8.
20. O'Brien JM, Milligan DA, Barton JR. Impact of high-dose corticosteroid therapy for patients with HELLP syndrome. Am J Obstet Gynecol 2000;183:921-4.
21. Martin JN, Thigpen BD, Rose CH, Cushman J, Moore A, May WL. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP syndrome. Am J Obstet Gynecol 2003;189: 830-4.
22. Sibai BM, Barton JR. Dexamethasone to improve maternal outcome in women with hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Obstet Gynecol 2005;193: 1587-90.
23. Martin JN, Files JC, Blake PG, Perry KG, Morrison JC, Norman PH. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP syndrome. Am J Obstet Gynecol 1995;172: 1107-27.
24. Isler CM, Rinehart BK, Terrone DA, Martin RW, Magann EF, Martin JN Jr. Maternal mortality associated with HELLP syndrome. Am J Obstet Gynecol 1999;181:924-8.
25. Hsieh YY, Chang CC, Li PC, Tsai HD, Tsai CH. Successful application of extracorporeal membrane oxygenation and intra-aortic balloon counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism. Am J Obstet Gynecol 2000;183:496-7.
26. Clark SL, Hankins GDV, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of the national registry. Am J Obstet Gynecol 1995;172:1158-69.
27. Benson MD, Lindberg RE. Amniotic fluid embolism, anaphylaxis and tryptase. Am J Obstet Gynecol 1996;175:737-8.
28. Robillard J, Gauvin F, Molinaro G, Leduc L, Adam A, Rivard GE. The syndrome of amniotic fluid embolism: a potential contribution of bradykinin. Am J Obstet Gynecol 2005;193: 1508-12.
29. Chou MM. Prenatal diagnosis and perinatal management of placenta previa accrea: past, present and future. Taiwanese J Obstet Gynecol 2004;43:64-71.
30. Chou MM, Ho ESC, Lee YH. Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol 2000;15:28-35.
31. Chou MM, Tseng JJ, Ho ESC, Hwang JI. Three-dimensional color power Doppler imaging in the assessment of utero-placental neovascularization in placenta previa incretapercreta. Am J Obstet Gynecol 2001;185:1257-61.
32. Chou MM, Hwang JI, Tseng JJ, Ho ESC. Internal iliac artery embolization before hysterectomy for placenta accreta. J Vasc Interv Radiol 2003;14:1195-9.
33. Chou MM, Tseng JJ, Ho ESC Usefulness of gray-scale ultrasound and complementary color Doppler ultrasound in the prenatal diagnosis of placenta previa accrete. Am J Obstet Gynecol 2005;192:1349-50.
34. Tseng SW, Lin CH, Hwang JI, Chen WH, Ho ESC, Chou MM. Experience with conservative strategy of uterine artery embolization in the treatment of placenta percreta in the first trimester of pregnancy. Taiwanese J Obstet Gynecol 2006 (in press).
35. Chauhan SP, Martin JN, Henrichs CE, Morrison JC, Magann EF. Maternal and perinatal complications with uterine rupture in 142,075 patients who attempted vaginal birth after cesarean delivery: a review of the literature. Am J Obstet Gynecol 2003;189:408-17.
36. Ofir K, Sheiner E, Levy A, Katz M, Mazor M. Uterine rupture: risk factors and pregnancy outcome. Am J Obstet Gynecol 2003;189:1042-6.
37. Landon MB, Hauth JC, Leveno KJ, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004;351:2581-9.
38. Macones GA, Cahill A, Stamilio DM, Ratcliffe S, Stevens E, Sammel M, Peipert J. Obstetric outcomes in women with two prior cesarean deliveries: is vaginal birth after cesarean delivery a viable option? Am J Obstet Gynecol 2005;192: 1223-8.
39. Zelop CM, Shipp TD, Repke JT, Cohen A, Caughey AB, Lieberman E. Uterine rupture during induced or augmented labor in gravid women with one prior cesarean delivery. Am J Obstet Gynecol 1999;181:882-6.
40. Asian H, Unlu E, Agar M, Ceylan Y. Uterine rupture associated with misoprostol labor induction in women with previous cesarean delivery. Eur J Obstet Gynecol Reprod Biol 2004;113: 45-8.
41. Cheung VY. Sonographic measurement of the lower uterine segment thickness in women with previous caesarean section. J Obstet Gynaecol Can 2005;27:674-81.
42. Thorp JA. Maternal death after second-trimester genetic amniocentesis. Obstet Gynecol 2005;106:409.
43. Thorp JA, Helfgott AW, King EA, Aaron A, Minyard AN. Maternal death after second-trimester genetic amniocentesis. Obstet Gynecol 2005;105:1213-5.
44. Elchalal U, Shachar IB, Peleg D, Schenker JG. Maternal mortality following diagnostic second-trimester amniocentesis. Fetal Diagn Ther 2004;19:195-8.
45. Ayadi S, Carbillon L, Varlet C, Uzan M, Pourrist JL. Fatal sepsis due to Escherichia coli after second-trimester amniocentesis. Fetal Diagn Ther 1998;13:98-9.
46. Mabie WC, Barton JR. Septic shock in pregnancy. Obstet Gynecol 1997;90:553-61.
47. Harry W, Foley MR. Treating septic shock in ob/gyn patients. Contemp Ob Gyn 2005;May 1.
48. Quzounian JG, Gherman RB. Shoulder dystocia: are historic risk factors reliable predictors? Am J Obstet Gynecol 2005;192: 1933-8.
49. Mehta SH, Blackwell SC, Hendler I, et al. Accuracy of estimated fetal weight in shoulder and neonatal birth injury. Am J Obstet Gynecol 2005;192:1877-81.
50. Gonen R, Bader D, Ajami M. Effects of a policy of elective cesarean delivery in cases of suspected fetal macrosomia on the incidence of brachial plexus injury and the rate of cesarean delivery. Am J Obstet Gynecol 2000;183:1296-300.
51. Minkin MJ. A no-fault approach to shoulder dystocia. Contemp Ob Gyn 2004;Dec. 1.
52. Jennett RJ, Tarby TJ, Kreinick CJ. Brachial plexus palsy: an old problem revisited. Am J Obstet Gynecol 1992;166:1673-7.
53. MacLennan A, Nelson KB, Hankins G, Speer M. Who will deliver our grandchildren? Implications of cerebral palsy litigation. JAMA 2005;294:1688-90.
54. Laros RK. Presidential address: Medical-legal issues in obstetrics and gynecology. Am J Obstet Gynecol 2005;192: 1883-9.